Dr. Jacqueline Vuky, MD
Claim this profileOregon Health and Science University
Studies Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
24 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
PD-L1 positive
2Non-Small Cell Lung Cancer
Stage IV
PD-L1 positive
Stage III
Affiliated Hospitals
Clinical Trials Jacqueline Vuky, MD is currently running
Tisotumab Vedotin
for Cancer
This trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumors and what side effects (unwanted effects) may occur. There are seven parts to this study. * In Part A, the treatment will be given to participants every 3 weeks (3-week cycles). * In Part B, participants will receive tisotumab vedotin on Days 1, 8, and 15 every 4-week cycle. * In Part C, participants will receive tisotumab vedotin on Days 1 and 15 of every 4-week cycle. * In Part D, participants will be given treatment on Day 1 of every 3-week cycle. Participants in Part D will get tisotumab vedotin with either: * Pembrolizumab or, * Pembrolizumab and carboplatin, or * Pembrolizumab and cisplatin * In Part E, participants will receive tisotumab vedotin on Days 1 and 15 of every 4-week cycle. * In Part F, participants will receive tisotumab vedotin on Days 1, 15, and 29 of every 6-week cycle. Participants in Part F will get tisotumab vedotin with pembrolizumab. * In Part G, participants will receive tisotumab vedotin on Days 1, 15, and 29 of every 6-week cycle. Participants in Part G will get tisotumab vedotin with pembrolizumab and carboplatin.
Recruiting1 award Phase 216 criteria
Radiation Therapy + Cisplatin
for Head and Neck Cancer
This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.
Recruiting1 award Phase 219 criteria
More about Jacqueline Vuky, MD
Clinical Trial Related7 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Jacqueline Vuky, MD has experience with
- Cisplatin
- Pembrolizumab
- Carboplatin
- RGX-104
- Nivolumab
- Docetaxel
Breakdown of trials Jacqueline Vuky, MD has run
Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Bladder Cancer
Head and Neck Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jacqueline Vuky, MD specialize in?
Jacqueline Vuky, MD focuses on Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jacqueline Vuky, MD currently recruiting for clinical trials?
Yes, Jacqueline Vuky, MD is currently recruiting for 3 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Jacqueline Vuky, MD has studied deeply?
Yes, Jacqueline Vuky, MD has studied treatments such as Cisplatin, Pembrolizumab, Carboplatin.
What is the best way to schedule an appointment with Jacqueline Vuky, MD?
Apply for one of the trials that Jacqueline Vuky, MD is conducting.
What is the office address of Jacqueline Vuky, MD?
The office of Jacqueline Vuky, MD is located at: Oregon Health and Science University, Portland, Oregon 97210 United States. This is the address for their practice at the Oregon Health and Science University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.